Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/220219
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGiménez Palomo, Anna-
dc.contributor.authorDodd, Seetal-
dc.contributor.authorAnmella, Gerard-
dc.contributor.authorCarvalho, André F.-
dc.contributor.authorScaini, Giselli-
dc.contributor.authorQuevedo, João-
dc.contributor.authorPacchiarotti, Isabella-
dc.contributor.authorVieta i Pascual, Eduard, 1963--
dc.contributor.authorBerk, Michael-
dc.date.accessioned2025-04-03T07:34:44Z-
dc.date.available2025-04-03T07:34:44Z-
dc.date.issued2021-07-06-
dc.identifier.issn1664-0640-
dc.identifier.urihttps://hdl.handle.net/2445/220219-
dc.description.abstractMitochondria are cellular organelles involved in several biological processes, especially in energy production. Several studies have found a relationship between mitochondrial dysfunction and mood disorders, such as major depressive disorder and bipolar disorder. Impairments in energy production are found in these disorders together with higher levels of oxidative stress. Recently, many agents capable of enhancing antioxidant defenses or mitochondrial functioning have been studied for the treatment of mood disorders as adjuvant therapy to current pharmacological treatments. A better knowledge of mitochondrial physiology and pathophysiology might allow the identification of new therapeutic targets and the development and study of novel effective therapies to treat these specific mitochondrial impairments. This could be especially beneficial for treatment-resistant patients. In this article, we provide a focused narrative review of the currently available evidence supporting the involvement of mitochondrial dysfunction in mood disorders, the effects of current therapies on mitochondrial functions, and novel targeted therapies acting on mitochondrial pathways that might be useful for the treatment of mood disorders.-
dc.format.extent26 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fpsyt.2021.546801-
dc.relation.ispartofFrontiers In Psychiatry, 2021, vol. 12-
dc.relation.urihttps://doi.org/10.3389/fpsyt.2021.546801-
dc.rightscc-by (c) Giménez-Palomo, A. et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationTrastorn bipolar-
dc.subject.classificationPsicopatologia-
dc.subject.classificationDepressió psíquica-
dc.subject.classificationADN mitocondrial-
dc.subject.otherManic-depressive illness-
dc.subject.otherPathological psychology-
dc.subject.otherMental depression-
dc.subject.otherMitochondrial DNA-
dc.titleThe Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec720306-
dc.date.updated2025-04-03T07:34:44Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid34295268-
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
247474.pdf1.32 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons